CClinicalTrials.gg
CompletedNCT01604603Updated Nov 6, 2013

The Clinical and Biochemical Characteristics in Women With Different Menstrual Pattern

An observational study in Regular Menstrual Cycle and Irregular Menstrual Cycle, sponsored by Taipei Medical University WanFang Hospital. Completed at 1 site in Taiwan. Open to female participants aged 13 Years to 45 Years. Per ClinicalTrials.gov, last updated 2013-11-06.

Sponsored by Taipei Medical University WanFang Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
470
Ages
13 Years to 45 Years
Sex
Female
01

Study summary

Background: Menstrual disturbance is the major complain in reproductive age women, the clinical and biochemical characteristics of women with different menstrual disturbance had not been well-understood. Objective: To study the clinical and biochemical characteristics of women with oligomenorrhea, amenorrhea, and premature ovarian failure. Method: Retrospective study, medical records reviewed in patients who visited to outpatient clinic of Reproductive Medicine in Taipei Medical University - Wan Fang Hospital form 2009 Jan. 1 to 2011 Nov. 31. Including criteria: Patients had sufficient medical records (anthropometric, endocrine, metabolic, lipid parameters) and age less than 45. Excluding criteria: (1) Women who experienced menarche \<3 years before the beginning of the study; (2) Women who received hormones or drugs for major medical diseases; (3) Women who presented ovarian cysts or ovarian tumors, uterine abnormality; (4) Women who were >45 years old.

02

Conditions studied

  • Regular Menstrual Cycle
  • Irregular Menstrual Cycle
03

In context

Lead sponsor

Taipei Medical University WanFang Hospital is the lead sponsor of 196 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients had sufficient medical records (anthropometric, endocrine, metabolic, lipid parameters) and age less than 45.

Inclusion criteria

  • Patients had sufficient medical records (anthropometric, endocrine, metabolic, lipid parameters) and age less than 45.

Exclusion criteria

Exclusion Criteria:

  1. Women who experienced menarche \<3 years before the beginning of the study;
  2. Women who received hormones or drugs for major medical diseases;
  3. Women who presented ovarian cysts or ovarian tumors, uterine abnormality;
  4. Women who were >45 years old.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
470 participants (actual)

Groups and cohorts

  • Control
  • Oligomenorrhea
  • Amenorrhea
  • premature ovarian failure
06

Study locations

1 site
  • WanFang Medical Center at Taipei Medical University
    Taipei City, 110, Taiwan
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 6, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01604603
Lead sponsor
Taipei Medical University WanFang Hospital
Responsible party
Ming-I Hsu (Taipei Medical University WanFang Hospital, Taipei Medical University WanFang Hospital) — Principal investigator
First posted
May 23, 2012
Start date
Apr 2012
Primary completion
Apr 2013
Completion
Apr 2013
Last update
Nov 6, 2013

Study contacts

Ming I Hsu, MD
principal investigator · Taipei Medical University WanFang Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion